Using sevoflurane to treat chronic leg ulcers
Official title: Analgesic and Healing Effect of Topical Sevoflurane for Chronic Venous Ulcers
Run by Charles University, Czech Republic · NCT05303805 · Data updated 2026-11-12
This study tests if using sevoflurane on painful leg ulcers can help reduce pain and improve healing compared to a regular rinse solution.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Charles University, Czech Republic Academic / other |
| Locations | 1 site (Prague) |
| Status | Recruiting |
| Started | May 2, 2022 |
| Main results expected | October 30, 2027 |
| Study ends | January 31, 2028 |
| Registry record updated | October 27, 2026 |
| Trial ID | NCT05303805 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients suffering from painful, non-healing tibial venous ulcers with a pain intensity rating above 4.
✕Probably not a fit
Patients with an allergy to sevoflurane or those unable to understand the pain-intensity questionnaire will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of topical sevoflurane in treating painful, non-healing leg ulcers. Patients will be randomly assigned to receive either sevoflurane or a standard rinse solution during their wound treatment. The study will monitor pain intensity, microbial colonization, and the healing process over a period of five days. The primary focus is on pain relief, with secondary outcomes related to ulcer healing and microbial management.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce pain and improve healing outcomes for patients with chronic leg ulcers.
How similar studies have gone: While the use of sevoflurane in this context is novel, similar approaches in pain management and wound healing have shown promise in other studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with painful (pain intensity on the numerical scale NRS 0-10 is NRS\>4) non- healing tibial venous ulcers Exclusion Criteria: * Allergy to sevoflurane * Inability to understand the pain-intensity questionnaire
Where it's running
-
Faculty Hospital Kralovske Vinohrady
Prague, Czechia Recruiting
Study contacts
- Principal investigator: Jiří Málek, M.D. — 3rd Medical Faculty of Charles University
- Study coordinator: Jiri Malek, M.D.
- Email: malekj@fnkv.cz
- Phone: +4202671622461
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using human placental membrane wraps with regular wound care to help heal stubborn diabetic foot and venous leg ulcers
This trial tests whether adding one of four human placental membrane wraps to standard wound care helps people with nonhealing diabetic foot or venous leg ulcers heal faster and more completely than standard care alone.
-
Evaluating new treatments for nonhealing diabetic foot and venous leg ulcers.
This study is testing whether new treatments for stubborn diabetic foot and leg ulcers can help people heal better when combined with standard care compared to just standard care alone.
-
Evaluating human placental membrane products for treating nonhealing diabetic foot and venous leg ulcers
This study is testing whether using human placental products along with regular care can help people with stubborn diabetic foot and leg ulcers heal better.
-
Evaluating new treatments for diabetic foot and venous leg ulcers
This study is testing different new treatments for stubborn diabetic foot and leg ulcers to see if they help heal better than the standard care alone.
-
Using music therapy to reduce pain from leg ulcer care
This study tests if music therapy can help reduce pain for adults getting treatment for leg ulcers.
-
Registry of Chronic Wounds and Ulcers
This study collects information from patients with chronic wounds and ulcers to see how well different treatments are working and to improve the quality of wound care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.